SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026571
Filing Date
2024-08-14
Accepted
2024-08-14 08:15:30
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rvph20240630_10q.htm   iXBRL 10-Q 1050900
2 EXHIBIT 31.1 ex_708377.htm EX-31.1 10844
3 EXHIBIT 31.2 ex_708378.htm EX-31.2 9549
4 EXHIBIT 32.1 ex_708379.htm EX-32.1 7516
  Complete submission text file 0001437749-24-026571.txt   5013851

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rvph-20240630.xsd EX-101.SCH 45561
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20240630_def.xml EX-101.DEF 285481
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20240630_lab.xml EX-101.LAB 238237
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20240630_pre.xml EX-101.PRE 310813
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvph-20240630_cal.xml EX-101.CAL 24103
59 EXTRACTED XBRL INSTANCE DOCUMENT rvph20240630_10q_htm.xml XML 844477
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38634 | Film No.: 241204303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)